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Improved continuation rate ofDepot-Medroxyprogesterone
acetate in adolescent mothers
IIAtim Omar, MD, Amy Fowler and Sandy D'Angelo, PhD
s~ction

ofAdolescent Medicine, Department ofPediatrics, University ofKentucky,
uxington, United States ofAmerica

Afluract: Poor compliance and high discontinuation rates of Depot-Medroxyprogesterone Acetate
(DMPA) and other contraceptive methods are major factors in the continuing problem of adolescent
~pw~cy.

In this study we attempted to detennine if providing comprehensive health care for teen
mothers and their babies would improve continuation rates of DMPA. Patients who started DMPA
bft"«n 111196 and 111/99 were included. Teen mothers and their babies received all their health care
in this clinic. supported by State funding. Key clements regarding DMPA in this clinic were
continuity of care, phone and mail reminders of appointments, free DMPA for patients without
insurance, counseling at each visit and available evening clinic. In the study period a total of299 (age
I 3·22 )'CliiS) patients were started on DMPA. Fifty-one percent were white, 47% black and 2% others.
Si\t)'·three percent were single, 20% married, 3% cohabitating and 14% undetennined (missing data).
Sc\"Cflty-eight percent had one baby and 22% more than one. A total of 189 patients (63.2%)
continued to be compliant after one year of use and 101 patients (33.8% of total) continued beyond
the second year. The most common side effect reported was bleeding or spotting (32%), However
only se\·en patients (2.3%) discontinued usc because of it. It is concluded that continuity of care
(same suiT and providers on each visit), regular counseling, flexible hours (evening appointments),
financial ease (free DMPA and no visit charge for those without insurance), combined Teen·Tot
health visits and regular reminders of appointments may help improve compliance and continuation
rales in teen mothers leading to better success in preventing repeat teen pregnancy.
K'P"f'rrls: Adolescence, adolescent contraception, injectable progesterone, Depot Provera, teenage
mothers, United States

C«rnpo11411fU: llatim Omar, MD, Associate Professor, Director of Adolescent Medicine and

Youna Parent programs, J422, Kentucky Clinic, University of Kentucky, Lexington, KY 40536-0284,
United States. Tel: 8$9-323-6426 ext. 307, Fax. 859-257·7706, E-mail: haomar2@pop.uky.cdu
Sdm/1114: January II, 2002. Rn>/s1d: January 18, 2002. Acupted: January 19, 2002.

1:'\'TRODUCTION

In a recent prospective study in adult
•-omen. continuation rates for DMPA were
ttpor1ed to be 6~'., 6 7%, S5% and S I "/o at
3. 6, 9 and 12 months respectively (1).
Prnious studies shO\\-ed various 12-month
continuation rates, ranging from 23 to 61%
{2-6). In adolescenu, DMPA continuation
nzes are c-.-en IO\\u (7,8). Pretreatment
~ling was found to enhance com·
plia:nce and improve continuation rates of
O~WA use (9). Other factors related to the

providers approach to the patient also
played a role in continuation of DMPA (1).
Menstrual changes are usually the most
common reasons for discontinuation of the
method (1,9). In this study, we reviewed the
clinical data in regard to DMPA in our
Young Parent Program in order to assess
continuation rates.

METHODS
A retrospective review of clinic data in
regard to DMPA use and continuation was
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done. Patients started on DMPA on or after
l/l/1996 were included. Total number of
patients included in the study was 299. See
Table 1 for demographics. The Young
Parents Program Clinic in which these
patients are enrolled provides comprehensive services that are different from most
conventional primary care clinics. The
Young Parents Program Clinic:
Provides comprehensive care: for both
teen mother and her baby. This includes
preventive care, reproductive services,
mental health and acute care visits. We
also provide care for siblings of the teen
as well as family counseling.
- Continuity of care: patients are seen by
the same staff and attending physicians
on each vis it.
Flexible hours: including evening clinic
to allow teens to attend school or work
during the day.
Financial incentives: patients with no
insurance are given DMPA free of
charge and no visit charge is applied if
they cannot afford it.
Counseling is provided prior to the start
of any birth control method and at each
visit.
- Telephone and/or mail reminders of
clinic appointments are routinely utilized.

RESULTS
Continuation· rote . of DMPA after 12
months was 63.2%. 33.8% of patients were
still using DMPA at 24 months and 15%
are still continuing after 36 months. This
percentage ·rate . at 36 months would
probably be higher when patients of more
than 24 and less than 36 months are added.
Seven percent of patients have completed
48 months. The most common adverse side
effect reported was spotting or bleeding,
which was present in 32% of patients,
however only seven patients (2.3%)
patients discontinued use because of it.
Other· side effects such as headaches,
mood changes and weight gain were
reported· in 2%, 4% and 31% respectively,
but were addressed during each visit and
counseling and education provided. None
of the patents discontinued use because of
these side effects. A desired side effect for
many patients was amenorrhea, which was
present in 47% of patients. It was not listed
as an adverse side effect, since many
patients considered it a convenience rather
than an annoyance.

DISCUSSION
This study looked at a special group of
patients in a special setting. The Young
Parents Program is one of the few programs
in the country that provides care to the
Table 1. Demographic characteristics of mother and baby at the same time. Many
adolescent mothers are more likely to miss
patients included in the study.
an appointment for themselves, but are
Mean Age
17.75 years
more
compliant when it comes to their
Standard Deviation
1.56 years
babies. Having simultaneous appointments
Median
17.94 years
allows these patients to save time and effort
Age Range
13-22 years
as well as fmancial savings related to
51%
White
transportation
expenses and missing work
Black
47%
or school.
Others
2%
Another factor that helps compliance is
63%
Single
the
evening clinic, which allows these
Married
20%
patients to avoid problems with their work
Cohabitating
3%
or school. A significant positive influence
Undetennined
14%
on
the patients is the continuity of care,
n~'"'ll
78%
which puts them at ease and makes it easier
t>l
22%
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to ask questions and to call if they have any
doubts about their birth control or any other
issue. All visits are physician visits with
education and counseling provided prior to
the start on DMPA and on each consecutive
visit. Counseling usually provides detailed
and honest information on all possible
health benefits as well as adverse effects,
which also helps compliance as in other
studies (1). Many adolescents, just as
adults, tend to forget appointments
especially when they are 2-3 months away.
In our clinic a dual system of telephone and
mail reminders is utilized and a simultaneous appointment for both mother and baby
is provided almost always. In addition, our
patient population can obtain all health care
needs in the clinic, including mental health
counseling and treatment allowing even
more reduction of lost time and effort
moving from clinic to clinic to obtain
different services.
Most adolescent mothers have some
degree of financial difficulty that interferes
with their access to health care as well as
their compliance. In our clinic fmancial
counseling is also routinely provided to
help patients utilize available State and
Federal resources for health insurance and
when neither is available, visit and
medication charges are waved. All these
factors are responsible for the much higher
rate of compliance noted here compared to
previous reports ( 1-8).
It has been reported that menstrual
disturbances were the main culprits for
discontinuation of DMPA (1,9). In this
study, bleeding was responsible for discontinuation in only seven patients (2.3%) that
had heavy bleeding. Most patients with
spotting and intermittent bleeding were able
to continue DMPA use.
CONCLUSION
Continuity of care, regular counseling,
flexible hours, financial incentives, combined teen-tot visits and regular reminders of

151

appointments may help to improve DMPA
continuation rates in teen mothers which
leads to reduction in repeat pregnane~.
ACKNOWLEDGEMENTS
This study was presented in part at the 15th
annual meeting of the North American
Society of Pediatric and Adolescent
Gynecology, Toronto, Canada, May 18-20
2001.
'
REFERENCES
I. Hubacher D, GocoN, Gonzalez B,
Taylor D. Factors affecting continuation
rates of DMPA. Contraception 2000;60:
345-51.
2. Westhoff C. Depot medroxyprogesterone acetate contraception. Metabolic
parameters and mood changes. J Reprod
Med 1994; 4l(supp15):401-6.
3. O'Dell CM, Forke CM, Polaneczky
MM, et al. Depot medroxyprogesterone
acetate or oral contraception in postpartum adolescents. Obstet Gynecol
1998;91:609-14.
4. Potter LS, Dalberth BT, Canamar R,
Betz M. Depot medroxyprogesterone
acetate pioneers. A retrospective study
at a North Carolina Health Department.
Contraception 1997;56:305-12.
5. Davidson AR, Kalmuss D, Cushman
LF, et al. Injectable contraceptive
discontinuation . and subsequent unintended pregnancy among low-income
women. Am J Public Health 1997;87:
1532-4.
6. Sekadde-Kigondu C, Mwathe EG,
Ruminjo JK, et a/. Acceptability and
discontinuation of Depot-medroxyprogesterone Acetate, IUCD and combined
pill in Kenya. East Afr Med J
1996;73:786-94.
7. O'Dell C, Forke C, Polaneczky M, et al.
Depot-medroxyprogesterone Acetate vs
oral contraceptive use in postpartum
adolescents. J Adolesc Health 1997;20:
127. Abstract.

152

USE OF DPMA IN ADOLESCENTMOTHERS

8. Cromer BA, Smith D, Blair JM, et a/. A
prospective study of adolescents who
choose among Levonorgestrel Implant
(Norplant), Medroxyprogesterone acetate
(Depot-medroxyprogesterone Acetate), or
the combined oral contraceptive pill as
contraception. Pediatrics 1994;94:687-94.

9. Lei ZW, Wu SC, Garceau RJ, et a/.
Effect of pretreatment counseling on
discontinuation rates in Chinese women
given depot-medroxyprogesterone acetate
for contraception. Contraception 1996;
53:357-61.
.

BlTS 'N Pl£C£S
Financial cost of social exclusion: follow up study of antisocial children into
adulthood
Objectives: To compare the cumulative costs of public services used through to
adulthood by individuals with three levels of antisocial behaviour in childhood.
Design: Costs applied to data of 10 year old children from the inner London
longitudinal study selectively followed up to adulthood.
Setting: Inner London borough.
Participants: 142 individuals divided into three groups in childhood: no problems,
conduct problems, and conduct disorder.
Main outcome measures: Costs in 1998 prices for public services (excluding
private, voluntary agency, indirect, and personal costs) used over and above basic
universal provision.
Results: By age 28, costs for individuals with conduct disorder w~re I 0.0 times
higher than for those with no problems (95% confidence interval of bootstrap ratio
3.6 to 20.9) and 3.5 times higher than for those with conduct problems (1.7 to 6.2).
Mean individual total costs were £70 0 I 9 for the conduct disorder group (bootstrap
mean difference from no problem group £62 898; £22 692 to £117 896) and £24
324 (£16 707; £6594 to £28 149) for the conduct problem group, compared with
£7423 for the no problem group. In all groups crime incurred the greatest cost,
followed by extra educational provision, foster and residential care, and state
benefits; health costs were smaller. Parental social class had a relatively small effect
on antisocial behaviour, and although substantial independent contributions came
from being male, having a low reading age, and attending more than two primary
schools, conduct disorder still predicted the greatest cost.
Conclusions: Antisocial behaviour in childhood is a major predictor of how much
an individual will cost society. The cost is large and falls on many agencies, yet few
agencies contribute to prevention, which could be cost effective.
ScottS, Knapp M, Henderson J, Maughan B. BMJ 2001;323:191.

